z-logo
open-access-imgOpen Access
Angiotensin II for the Treatment of Vasodilatory Shock
Author(s) -
Ashish K. Khanna,
Shane English,
Xueyuan S. Wang,
Kealy R. Ham,
James A. Tumlin,
Harold M. Szerlip,
Laurence W. Busse,
Laith Altaweel,
Timothy E. Albertson,
Caleb Mackey,
Michael T. McCurdy,
David W. Boldt,
Stefan Chock,
Paul J. Young,
Kenneth Krell,
Richard G. Wunderink,
Marlies Ostermann,
Raghavan Murugan,
Michelle N. Gong,
Rakshit Panwar,
Johanna Hästbacka,
Raphaël Favory,
Balasubramanian Venkatesh,
Bruce Thompson,
Rinaldo Bellomo,
Jeffrey Jensen,
Stew Kroll,
Lakhmir S. Chawla,
George F. Tidmarsh,
Adam M. Deane
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1704154
Subject(s) - medicine , vasodilation , angiotensin ii , shock (circulatory) , cardiology , blood pressure
Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom